Abstract Submission


  • Abstract Text: All abstracts should be prepared in word processing application (e.g. MS Word) using 12 point normal Times New Roman with single spacing. It should be clearly and concisely written in English.
  • It should be organized in the following order: Title, Author(s), Affiliation(s), Abstract and Keywords (up to 5).
  • Title: The title should be concise and written in title case, centred, and in 16 point bold Times New Roman font at the top of page. Abbreviations should be avoided within the title.
  • Author(s) & Affiliation(s): Author(s) names should be listed together in full and separated by commas. The name of the presenting author should be underlined. Provide exact and correct author names as these will be indexed in official archives. Affiliations should be keyed to the author’s name with superscript numbers and be listed as follows: Laboratory, Institute, Department, Organization, City, State abbreviation (USA, Canada, Australia), and Country (without detailed address information such as city zip codes or street names).


Jorg Taubel¹, Sara Fernandes¹, Ulrike Lorch¹, and Georg Ferber²
¹Richmond Pharmacology Ltd., London, United Kingdom
²Statistik Georg Ferber GmbH, Riehen, Switzerland

  • Abstract: The length of the abstract should not exceed 300 words. In the abstract, minimize the use of abbreviations and do not cite references. Abstract should not contain any non-standard symbols, equations or tabular material. Do not indent.
  • Abstracts must be organized and structured as follows: Background, Methods, Results, Conclusion.
  • It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or Scientific facts in the abstract text will be reproduced as typed by the author. Abstract titles will be subject to a spell check if the abstract is selected for presentation.
  • The deadline for late-breaking abstract submission is on 1st September 2019.